Clinical Trial Update: Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old

View source ↗

Summary

This completed clinical trial evaluates whether anti-Müllerian hormone (AMH) and inhibin B levels can predict IVF outcomes in women over 38.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Reproductive Medicine Associates of New Jersey | Conditions: AMH Levels, Inhibin B Levels | Status: COMPLETED